secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001213900-25-012896
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband receives USPTO Notice of Allowance for Aversa abuse deterrent patent
------------------------------------------------------------------------------

- Notice of Allowance received Feb 3, 2025 for patent app 18/369,241 covering Aversa abuse deterrent transdermal systems.
- US patent expected to issue after administrative processes; expands US IP protection for abuse deterrent transdermal portfolio.
- Lead product Aversa Fentanyl could become first abuse-deterrent opioid patch; potential peak US sales $80-200M per Health Advances.
- Aversa technology already protected by patents in 46 countries including US, Europe, Japan, China, Canada, Mexico, Australia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390025012896/0001213900-25-012896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390025012896/ea0230859-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-012896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer